全文获取类型
收费全文 | 1315889篇 |
免费 | 102488篇 |
国内免费 | 2900篇 |
专业分类
耳鼻咽喉 | 18747篇 |
儿科学 | 45291篇 |
妇产科学 | 35999篇 |
基础医学 | 186381篇 |
口腔科学 | 34308篇 |
临床医学 | 114853篇 |
内科学 | 267385篇 |
皮肤病学 | 28629篇 |
神经病学 | 103759篇 |
特种医学 | 52701篇 |
外国民族医学 | 662篇 |
外科学 | 201525篇 |
综合类 | 29120篇 |
现状与发展 | 2篇 |
一般理论 | 378篇 |
预防医学 | 97874篇 |
眼科学 | 28450篇 |
药学 | 98135篇 |
10篇 | |
中国医学 | 3371篇 |
肿瘤学 | 73697篇 |
出版年
2019年 | 10130篇 |
2018年 | 14287篇 |
2017年 | 10906篇 |
2016年 | 11897篇 |
2015年 | 13650篇 |
2014年 | 18833篇 |
2013年 | 28203篇 |
2012年 | 38666篇 |
2011年 | 40702篇 |
2010年 | 24392篇 |
2009年 | 23277篇 |
2008年 | 38832篇 |
2007年 | 41418篇 |
2006年 | 41484篇 |
2005年 | 40344篇 |
2004年 | 39279篇 |
2003年 | 37884篇 |
2002年 | 37094篇 |
2001年 | 64948篇 |
2000年 | 67394篇 |
1999年 | 57261篇 |
1998年 | 15490篇 |
1997年 | 14025篇 |
1996年 | 14466篇 |
1995年 | 13663篇 |
1994年 | 12966篇 |
1993年 | 11953篇 |
1992年 | 44975篇 |
1991年 | 43834篇 |
1990年 | 42595篇 |
1989年 | 40489篇 |
1988年 | 37198篇 |
1987年 | 36523篇 |
1986年 | 33889篇 |
1985年 | 32484篇 |
1984年 | 24318篇 |
1983年 | 20412篇 |
1982年 | 11808篇 |
1981年 | 10762篇 |
1979年 | 21496篇 |
1978年 | 14919篇 |
1977年 | 12618篇 |
1976年 | 11751篇 |
1975年 | 12685篇 |
1974年 | 14758篇 |
1973年 | 14225篇 |
1972年 | 13047篇 |
1971年 | 11822篇 |
1970年 | 11126篇 |
1969年 | 10102篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Molnár B. Aroca S. Dobos A. Orbán K. Szabó J. Windisch P. Stähli A. Sculean A. 《Clinical oral investigations》2022,26(12):7135-7142
Clinical Oral Investigations - To evaluate t he long-term outcomes following treatment of RT 1 multiple adjacent gingival recessions (MAGR) using the modified coronally advanced tunnel (MCAT) with... 相似文献
2.
3.
4.
5.
6.
7.
8.
Qiangsheng He Chongfei Huang Xiwen Qin Yuanyuan Yu Di Tang Junjie Huang Zi Chong Kuo Yuyao Ling Deli Mao Bin Xia Wenjing Li Kuiqing Lu Man Yang Yulong He Wenbo Meng Jinqiu Yuan Yihang Pan 《International journal of cancer. Journal international du cancer》2023,153(5):942-949
Recent epidemiological studies suggested that proton pump inhibitor (PPI) use was associated with an increased risk of biliary tract cancer (BTC), however, confounders were not adequately controlled. Our study aimed to evaluate PPI use and subsequent risk of BTC and its subtypes in three well-established cohorts. We conducted a pooled analysis of the subjects free of cancers in UK Biobank (n = 463 643), Nurses' Health Study (NHS, n = 80 235) and NHS II (n = 95 869). Propensity score weighted Cox models were used to estimate marginal HRs of PPIs use on BTC risk, accounting for potential confounders. We documented 284 BTC cases in UK Biobank (median follow-up: 7.6 years), and 91 cases in NHS and NHS II cohorts (median follow-up: 15.8 years). In UK biobank, PPI users had a 96% higher risk of BTC compared to nonusers in crude model (HR 1.96, 95% CI 1.44-2.66), but the effect was attenuated to null after adjusting for potential confounders (HR 0.95, 95% CI 0.60-1.49). PPI use was not associated with risk of BTC in the pooled analysis of three cohorts (HR 0.93, 95% CI 0.60-1.43). We also observed no associations between PPI use with risk of intrahepatic (HR 1.00, 95% CI 0.49-2.04), extrahepatic bile duct (HR 1.09, 95% CI 0.52-2.27) and gallbladder cancers (HR 0.66, 95% CI 0.26-1.66) in UK Biobank. In summary, regular use of PPIs was not associated with the risk of BTC and its subtypes. 相似文献
9.
多囊卵巢综合征(polycystic ovary syndrome,PCOS)是一种内分泌代谢紊乱综合征,临床表现高度异质性。肥胖是PCOS异质性临床表现之一,超过50%的PCOS患者超重或肥胖。肥胖型PCOS主要表现为高雄激素血症、中心型肥胖和糖脂代谢紊乱,非肥胖型PCOS主要表现为黄体生成激素(luteinizing hormone,LH)水平异常升高。尽管肥胖型和非肥胖型PCOS均存在内分泌代谢异常,然而肥胖可加重PCOS糖脂代谢紊乱;肥胖型PCOS还表现脂肪代谢的异常。综述肥胖型PCOS患者的临床特征、性激素水平、糖脂代谢特征,旨在为肥胖型和非肥胖型PCOS患者新的分型诊治提供参考。 相似文献
10.
Raymond J. Chan RN PhD Vivienne E. Milch MBBS MHPol Fiona Crawford-Williams PhD Oluwaseyifunmi Andi Agbejule BRadTherapy Ria Joseph MNutrDiet Jolyn Johal BND Narayanee Dick BSc Matthew P. Wallen PhD Julie Ratcliffe PhD Anupriya Agarwal MBBS Larissa Nekhlyudov MD Matthew Tieu PhD Manaf Al-Momani BPharm Scott Turnbull PhD Rahul Sathiaraj MPH Dorothy Keefe MBBS MD Nicolas H. Hart PhD 《CA: a cancer journal for clinicians》2023,73(6):565-589
Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, and present the best available evidence to inform policy and planning regarding patient navigation across the cancer continuum. Systematic reviews examining navigation in cancer care were identified in the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, Cumulative Index of Nursing and Allied Health (CINAHL), Epistemonikos, and Prospective Register of Systematic Reviews (PROSPERO) databases and in the gray literature from January 1, 2012, to April 19, 2022. Data were screened, extracted, and appraised independently by two authors. The JBI Critical Appraisal Checklist for Systematic Review and Research Syntheses was used for quality appraisal. Emerging literature up to May 25, 2022, was also explored to capture primary research published beyond the coverage of included systematic reviews. Of the 2062 unique records identified, 61 systematic reviews were included. Fifty-four reviews were quantitative or mixed-methods reviews, reporting on the effectiveness of cancer patient navigation, including 12 reviews reporting costs or cost-effectiveness outcomes. Seven qualitative reviews explored navigation needs, barriers, and experiences. In addition, 53 primary studies published since 2021 were included. Patient navigation is effective in improving participation in cancer screening and reducing the time from screening to diagnosis and from diagnosis to treatment initiation. Emerging evidence suggests that patient navigation improves quality of life and patient satisfaction with care in the survivorship phase and reduces hospital readmission in the active treatment and survivorship care phases. Palliative care data were extremely limited. Economic evaluations from the United States suggest the potential cost-effectiveness of navigation in screening programs. 相似文献